Kyntra Bio share price logo

Kyntra Bio

NASDAQ: KYNB

$4.85

-0.51

(-9.51%)

as on

Kyntra Bio Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.86
    $5.50
    downward going graph

    -0.21%

    Downside

    13.40%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kyntra Bio share price movements today

Previous Close
$5.36
Open
$5.50
Volume
247.1K
Market Cap
$21.7M
Day's Low - High
$4.86 - $5.50

Kyntra Bio Historical Returns

1 Month Return
-31.69 %
3 Month Return
-32.92 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kyntra Bio Stock Fundamentals & Key Indicators

Check Kyntra Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.7M

EPS (TTM)

58.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.09

Industry PE ratio

-3.02

PEG Ratio

0.00

EBITDA

-94.0M

Revenue (TTM)

4.6M

Profit Margin

18.15%

Return On Equity TTM

-605.53%

Kyntra Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyntra Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$21.7MNA0.0918.15%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Analyst Recommendation on Kyntra Bio Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Kyntra Bio. Average target price of $35

Kyntra Bio Share Price Target

Get share price movements and forecasts by analysts on Kyntra Bio.

Current Price

$4.85

Analyzed by

2 Analysts

High

$35

0

Low

$35

Kyntra Bio target price $0, a slight upside of 0% compared to current price of $4.85. According to 2 analysts rating.

Indian Investors' Interest in Kyntra Bio Stock

Search interest for Kyntra Bio Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-60% versus previous 30 day period

Kyntra Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
25
0
46
-123
2
1
1
1
3
-1
Gross Profit
-32
-31
41
-102
2
1
0
1
0
-1
Operating Income
-49
-46
-16
-91
-14
-11
-5
-14
-13
-17
EBITDA
-46
-44
-12
-91
-14
-11
-10
-20
-12
-49
Interest Expense
2
1
4
-
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-49
-47
-17
-87
-16
-13
-13
-14
-15
11
Income Tax Expense
0
0
0
0
0
0
-
-
-
0
Net Income
-32
-15
-17
17
4
-7
148
37
-15
11
Net Profit Margin
-128.01%
-3156.51%
88.57%
83.23%
78.86%
77.30%
87.55%
136.26%
-9.84%
100.14%

Kyntra Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
125
212
256
176
235
140
46
29
6
Gross Profit
-70
-22
255
167
-213
120
42
14
5
Operating Income
-122
-86
-89
-191
-288
-301
-322
-150
-45
EBITDA
-104
-68
-52
-164
-333
-282
-305
-142
-57
Interest Expense
9
10
2
2
1
1
8
8
8
Depreciation
6
6
21
22
14
10
9
2
0
Income Before Tax
-125
-86
-76
-188
-289
-293
-323
-153
-58
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-126
-86
-76
-189
-290
-293
-284
-47
183
Net Profit Margin
-56.38%
-10.74%
99.55%
94.97%
-90.89%
85.59%
91.53%
47.47%
91.37%

Kyntra Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-32
-15
-17
17
4
-7
200
-14
-15
11
Operating Cash Flow
-59
-39
-8
-30
2
12
-1
-18
-13
-3
Investing Cash Flow
51
72
0
1
0
0
87
-51
3
17
Financing Cash Flow
0
0
0
0
0
0
-85
0
0
0
Change in Cash
-7
34
-9
-28
4
13
-1
-70
-10
13

Kyntra Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-86
-76
-189
-290
-293
-284
-47
183
Operating Cash Flow
-66
-76
-78
81
-82
-145
-315
-137
-4
Investing Cash Flow
69
-522
120
452
-426
89
153
125
35
Financing Cash Flow
496
13
-4
13
0
46
122
0
-86
Change in Cash
499
-584
37
552
-507
-15
-42
-11
-54

Global Institutional Holdings in Kyntra Bio

Check out the Institutions with significant holdings in Kyntra Bio.

Funds
Holdings
T. ROWE PRICE QUANTITATIVE MANAGEMENT FUNDS, INC.
10.41%
Fidelity Commonwealth Trust II
4.19%
VANGUARD INDEX FUNDS
3.87%
Vanguard
3.86%
TIAA-CREF Funds
2.05%

Kyntra Bio News & Key Events

  • img

    Today's Timeline - 01 October

    Thu, 05:30 PM

    -

    Kyntra Bio appoints Andrew Singer as independent director, following Maykin Ho's resignation, enhancing governance in oncology and rare disease focus.

Insights on Kyntra Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -15.19M → 11.97M (in $), with an average increase of 226.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 222.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 791.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KYNB stock has moved down by -20.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 3.73M → -1.47M (in $), with an average decrease of 139.4% per quarter

About Kyntra Bio

Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to create groundbreaking therapies aimed at tackling conditions like anemia, various fibrotic disorders, and different forms of cancer. Established by Thomas B. Neff on September 29, 1993, the firm's main offices are situated in San Francisco, California.
OrganisationKyntra Bio
Headquarters350 Bay Street, San Francisco, CA, 94133, US
IndustryBiotechnology
CEOThane Wettig

Key Management of Kyntra Bio

Name

Title

Mr. Thane Wettig

CEO & Director

Mr. David DeLucia

Senior VP & CFO

Mr. John Alden

Corporate Secretary & General Counsel

Ms. Michelle Simonetti

Head of People and Culture & Executive Director

Dr. Carrie Brownstein M.D.

Chief Medical Officer

Ms. Gaia Vasiliver-Shamis

Director of IR & Communications - LifeSci Advisors

Ms. Carol Gaddum

Vice President of Product Development

FAQs

What is Kyntra Bio share price today?

Kyntra Bio share price today is $4.85 as on at the close of the market. Kyntra Bio share today touched a day high of $5.50 and a low of $4.86.

What is the 52 week high and 52 week low for Kyntra Bio share?

Kyntra Bio share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Kyntra Bio stock price today i.e. is closed at $4.85,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kyntra Bio's market capitalisation today?

Kyntra Bio market capitalisation is $0.00T as on .

How to invest in Kyntra Bio Stock (KYNB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyntra Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kyntra Bio Stock (KYNB) from India?

Indian investors can start investing in Kyntra Bio (KYNB) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Kyntra Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Kyntra Bio share’s latest price of $4.85 as on October 17, 2026 at 8:46 am IST, you will get 2.0619 shares of Kyntra Bio. Learn more about fractional shares .